GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by City State Bank

City State Bank boosted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 51.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 561 shares of the company’s stock after buying an additional 191 shares during the period. City State Bank’s holdings in GE HealthCare Technologies were worth $44,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of GEHC. Acadian Asset Management LLC purchased a new position in GE HealthCare Technologies in the 2nd quarter valued at $629,000. Quest Partners LLC purchased a new position in GE HealthCare Technologies in the 2nd quarter valued at $95,000. Ashton Thomas Private Wealth LLC purchased a new position in GE HealthCare Technologies in the 2nd quarter valued at $49,000. LPL Financial LLC grew its position in GE HealthCare Technologies by 17.7% in the 2nd quarter. LPL Financial LLC now owns 397,120 shares of the company’s stock valued at $30,944,000 after buying an additional 59,860 shares during the last quarter. Finally, Oppenheimer & Co. Inc. grew its position in GE HealthCare Technologies by 27.8% in the 2nd quarter. Oppenheimer & Co. Inc. now owns 20,716 shares of the company’s stock valued at $1,614,000 after buying an additional 4,509 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the transaction, the chief executive officer now owns 24,298 shares of the company’s stock, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.27% of the stock is currently owned by corporate insiders.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $85.36 on Tuesday. GE HealthCare Technologies Inc. has a 52 week low of $71.31 and a 52 week high of $94.55. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The firm’s 50-day simple moving average is $82.21 and its 200 day simple moving average is $84.22. The firm has a market capitalization of $39.00 billion, a PE ratio of 23.45, a P/E/G ratio of 2.90 and a beta of 1.11.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, beating the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The firm had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. During the same quarter in the previous year, the company posted $0.99 EPS. The firm’s revenue for the quarter was up .9% on a year-over-year basis. On average, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be paid a $0.035 dividend. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 annualized dividend and a yield of 0.16%. GE HealthCare Technologies’s payout ratio is presently 3.85%.

Analyst Ratings Changes

Several equities research analysts have commented on GEHC shares. BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a research report on Wednesday, September 18th. UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and decreased their target price for the stock from $84.00 to $74.00 in a research report on Thursday, September 26th. Evercore ISI boosted their target price on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. Wells Fargo & Company boosted their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. Finally, Stifel Nicolaus boosted their target price on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research report on Monday, September 30th. One research analyst has rated the stock with a sell rating, four have given a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $96.00.

View Our Latest Report on GEHC

GE HealthCare Technologies Profile

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

See Also

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.